These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 14525632)

  • 21. The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy.
    Eskow KL; Gupta V; Alam S; Park JY; Bishop C
    Pharmacol Biochem Behav; 2007; 87(3):306-14. PubMed ID: 17553556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics.
    Sumiyoshi T; Bubenikova-Valesova V; Horacek J; Bert B
    Adv Ther; 2008 Oct; 25(10):1037-56. PubMed ID: 18839076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Buspirone in Rett syndrome respiratory dysfunction.
    Andaku DK; Mercadante MT; Schwartzman JS
    Brain Dev; 2005 Sep; 27(6):437-8. PubMed ID: 15967617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats.
    Haleem DJ; Samad N; Haleem MA
    Pharmacol Biochem Behav; 2007 May; 87(1):115-21. PubMed ID: 17498786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apneusis.
    Shim C; Williams MH
    Arch Intern Med; 1978 Oct; 138(10):1505-8. PubMed ID: 708172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
    de Boer SF; Koolhaas JM
    Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic buspirone treatment normalizes regional serotonin synthesis in the olfactory bulbectomized rat brain: an autoradiographic study.
    Watanabe A; Hasegawa S; Nishi K; Nguyen KQ; Diksic M
    Brain Res Bull; 2006 Mar; 69(2):101-8. PubMed ID: 16533657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transient mutism after brain stem infarction.
    Erşahin Y
    Acta Neurochir (Wien); 1999; 141(9):1020. PubMed ID: 10610613
    [No Abstract]   [Full Text] [Related]  

  • 29. Trigeminal neuralgia due to pontine infarction.
    Peker S; Akansel G; Sun I; Pamir NM
    Headache; 2004; 44(10):1043-5. PubMed ID: 15546271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Central neurogenic hyperventilation associated with a pontine infarction].
    Sentíes Madrid H; Téllez Zenteno JF; García Ramos G; Vega Boada F; Dávila Maldonado L; Peláez Luna M
    Rev Invest Clin; 2000; 52(5):584-6. PubMed ID: 11195188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transient mutism after brain stem infarction (ref. Acta Neurochirurgia 1999, 141: 209-213).
    Erşahin Y
    Acta Neurochir (Wien); 1999; 141(8):902. PubMed ID: 10536732
    [No Abstract]   [Full Text] [Related]  

  • 32. Repeated cortisol administration attenuates the EEG response to buspirone in healthy volunteers: evidence for desensitization of the 5-HT1A autoreceptor.
    McAllister-Williams RH; Massey AE; Fairchild G
    J Psychopharmacol; 2007 Nov; 21(8):826-32. PubMed ID: 17715208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical implications of headache in lacunar stroke: relevance of site of infarct.
    Arboix A; Grau-Olivares M; García-Eroles L; Massons J; Comes E; Targa C
    Headache; 2006; 46(7):1172-80. PubMed ID: 16866721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormonal response to buspirone is not impaired in major depression.
    Navinés R; Gómez-Gil E; Martín-Santos R; de Osaba MJ; Escolar G; Gastó C
    Hum Psychopharmacol; 2007 Aug; 22(6):389-95. PubMed ID: 17563921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Region-specific changes in 5-HT1A agonist-induced Extracellular signal-Regulated Kinases 1/2 phosphorylation in rat brain: a quantitative ELISA study.
    Buritova J; Berrichon G; Cathala C; Colpaert F; Cussac D
    Neuropharmacology; 2009 Feb; 56(2):350-61. PubMed ID: 18809418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of sex and sex steroids in mediating pituitary-adrenal responses to acute buspirone treatment in sheep.
    Broadbear JH; Pierce BN; Clarke IJ; Canny BJ
    J Neuroendocrinol; 2005 Dec; 17(12):804-10. PubMed ID: 16280027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validating an Ataxia Functional Composite Scale in spinocerebellar ataxia.
    Assadi M; Leone P; Veloski JJ; Schwartzman RJ; Janson CG; Campellone JV
    J Neurol Sci; 2008 May; 268(1-2):136-9. PubMed ID: 18191149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-HT-1A receptor responsiveness following subchronic administration of buspirone.
    Khan A; Haleem DJ
    Pak J Pharm Sci; 2006 Oct; 19(4):333-7. PubMed ID: 17105715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrinsic activity and comparative molecular dynamics of buspirone analogues at the 5-HT(1A) receptors.
    Strzelczyk AA; Jarończyk M; Chilmonczyk Z; Mazurek AP; Chojnacka-Wójcik E; Sylte I
    Biochem Pharmacol; 2004 Jun; 67(12):2219-30. PubMed ID: 15163553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
    Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
    Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.